Co-crystallization of nonsteroidal anti-inflammatory drug fenamates (N-phenylanthranilic acid (N-PA), niflumic acid (NFA), flufenamic acid (FFA), tolfenamic (TFA) and mefenamic acids (MFA)) with 4,4′-bipyridine (BP) has resulted in the formation of co-crystals with a 2:1 molar ratio. The Crystal Packing Similarity analysis has revealed that the packing arrangement of the [N-PA+BP], [TFA+BP] and [MFA+BP] co-crystals consists of discrete fragments of the crystal structures of initial APIs connected to each other by BP molecules. In case of [FFA+BP], the cocrystal contains a previously unseen packing arrangement of FFA molecules which may be a fragment of a new polymorphic FFA form. Differential scanning calorimetry studies show a goodcorrelation between the co-crystal melting temperature and the melting points of the corresponding pure APIs. The enthalpies of co-crystal formation are small, which indicates that the packing energy gain only originates from weak van der Waals interactions between the API and BP molecules.